Recombinant human GDF11 protein (Animal Free)
- Bioactive
- 각 태그의 뜻
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Recombinant human GDF11 protein (Animal Free) is a Human Full Length protein, in the 299 to 407 aa range, expressed in Escherichia coli, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE, FuncS, HPLC.
대체 명칭 보기
BMP11, GDF11, Growth/differentiation factor 11, GDF-11, Bone morphogenetic protein 11, BMP-11
- FuncS
Unknown
Functional Studies - Recombinant human GDF11 protein (Animal Free) (AB218103)
Functional analysis of ab218103
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant human GDF11 protein (Animal Free) (AB218103)
SDS-PAGE analysis of ab218103 (1μg) stained with Coomassie blue :
Lane 1 : Non-reduced
Lane 2 : Reduced
4-20% Tris-Glycine gel
Reactivity 정보
제품 세부 정보
This product shares 100% homology with amino acids 297-405 of Rat and Mouse GDF11.
This product was previously labelled as BMP11, BMP11 + GDF8 / Myostatin
서열 정보
특성 및 보관 정보
제형
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
일반 정보
기능
Secreted signal that acts globally to regulate anterior/posterior axial patterning during development. May play critical roles in patterning both mesodermal and neural tissues (By similarity). It is required for proper vertebral patterning and orofacial development (PubMed : 31215115). Signals through activin receptors type-2, ACVR2A and ACVR2B, and activin receptors type-1, ACVR1B, ACVR1C and TGFBR1 leading to the phosphorylation of SMAD2 and SMAD3 (PubMed : 28257634).
서열 유사성
Belongs to the TGF-beta family.
Post-translational modifications
Synthesized as large precursor molecule that undergoes proteolytic cleavage by furin-like proteases (PubMed:31215115). This produces an inactive form consisting of the mature C-terminal portion non-covalently bound to its cleaved N-terminal propeptide. Activation of the mature form requires additional cleavage of the propeptide by a tolloid-like metalloproteinase.
타겟 정보
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com